In fact, the anti-proliferative effect exerted by ATRA in HCC-1599 cells is entirely recapitulated by the RARα agonist, AM580, which is incapable of binding and activating RARβ at the concentrations used in our experimental conditions. This evidence concerns the gene RARA and hepatocellular carcinoma.